Roth, Daniel http://orcid.org/0000-0002-4128-0032
Larsson, Erik
Strand, Joanna
Ljungberg, Michael
Sjögreen Gleisner, Katarina
Funding for this research was provided by:
Cancerfonden (21-1754-Pj01H)
Fru Berta Kamprads Stiftelse (FBKS-2020-13, FBKS-2019-44)
Lund University
Article History
Received: 20 June 2023
Accepted: 6 December 2023
First Online: 3 January 2024
Declarations
:
: Both patients were included in the Iluminet clinical trial (EUDRACT 2011-000240-16, NCT01456078) and gave their informed consent. The trial has been approved by the local ethics committee (Regionala Etikprövningsnämden Lund, ref. no. 2011/287) and by the national regulatory authorities.All animal experiments were performed in accordance with national legislation on laboratory animal protection and permitted by the local Ethics Committee for Animal Research at Lund University (permit number 4350–20).
: The patients gave written informed consent to participation and publication of data related to the trial and gave verbal consent to contribute with the measurements published herein.
: KSG, ML, DR, EL, and JS declare that they have nothing to disclose.